SURMAX PREMIX DIN 02421062
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | AVILAMYCIN 100 G |
|---|
| Dosage form | Drug Premix |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 30-May-2014 |
|---|
| Current status date | 28-Nov-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AVILAMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02436760 | SURMAX 200 PREMIX | ELANCO CANADA LIMITED | Drug Premix | AVILAMYCIN 200 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 21575 | 2018-11-28 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION, NEW SPECIES - SWINE, PRODUCT NAME CHANGE |
| 20430 | 2018-02-02 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 15277 | 2014-02-18 | New Drug Submission (NDS) | |
Request a quote for SURMAX PREMIX
How to read a Canadian DIN record